Last patient visit in Phase IIa study with RHB-104 for multiple sclerosis
3 August 2016 | By RedHill Biopharma Ltd.
The last patient visit has been completed in the Phase IIa study evaluating RHB-104 in patients treated for relapsing-remitting multiple sclerosis (RRMS)...